Best in Biotech 12 Dec 2017Grab the Tissues: Here are the 8 Biggest European Biotech Clinical Failures of 2017 As 2016 was a tough year for biotech, 2017 was under pressure to turn things around. Although there has been… December 12, 2017 - 7 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 20 Mar 2017French Biotech fails Second Phase II Trial for Cardiovascular Disease Cerenis therapeutic's lead candidate CER-001 has failed Phase II for the treatment of patients with post-acute coronary syndrome (ACS). The… March 20, 2017 - 3 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
News and Trends 3 Sep 2014EMA give Orphan Drug Designation to the CER-001 of Cerenis Cerenis Therapeutics, the biopharmaceutical company developing CER-001, an engineered human apoA-I-containing pre-beta HDL mimetic, for the treatment of cardiovascular disease,… September 3, 2014 - 3 minutesmins - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email